Shasun Pharma gains as Sequent Scientific picks up 5.8% stake

10 Jun 2014 Evaluate

Shasun Pharmaceuticals is currently trading at Rs. 155.10, up by 0.45 points or 0.29% from its previous closing of Rs. 154.65 on the BSE.

The scrip opened at Rs. 154.10 and has touched a high and low of Rs. 156.70 and Rs. 152.40 respectively. So far 5720 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 168.50 on 09-May-2014 and a 52 week low of Rs. 45.60 on 26-Jun-2013.

Last one week high and low of the scrip stood at Rs. 158.70 and Rs. 141.65 respectively. The current market cap of the company is Rs. 929.82 crore.

The promoters holding in the company stood at 41.97% while Institutions and Non-Institutions held 16.41% and 41.63% respectively.

Sequent Scientific has acquired 35,00,000 equity shares in Shasun Pharmaceuticals through preferential allotment mode, for around Rs 38.5 crore. Following the acquisition, the Bangalore-based company would have 5.82% share in Shasun Pharmaceuticals’ total equity shares.

Earlier, Sequent Scientific, which has launched a joint venture firm with Shasun Pharma some time back, has been planning to pick up a minority stake of around 16% in the company with an investment of around Rs 116 crore.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×